Skip to main content

Loading market ticker...

Natural Capsules (NSE:NATCAPSUQ): What Is the EGM Scheduled for September 9, 2026?

Natural Capsules (NSE:NATCAPSUQ): What Is the EGM Scheduled for September 9, 2026?

Source: Krish Capital Pty Ltd

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn More

Natural Capsules Limited (NSE:NATCAPSUQ) filed an intimation on August 18, 2026, under Regulation 30 of the SEBI LODR Regulations, 2015, enclosing newspaper advertisements published in Business Line (English) and Sanjevani (Kannada) notifying equity shareholders of an Extraordinary General Meeting to be held on Wednesday, September 9, 2026, at 12:00 PM IST via Video Conferencing or Other Audio Visual Means.

Key Highlights

  • The EGM is scheduled for Wednesday, September 9, 2026, at 12:00 PM IST, to be conducted through Video Conferencing or Other Audio Visual Means.
  • Newspaper advertisements were published in Business Line (English) and Sanjevani (Kannada) on August 18, 2026, to reach equity shareholders across geographies.
  • The filing was made by Company Secretary and Compliance Officer Akshay Dutta under Regulation 30 of the SEBI LODR Regulations, 2015.
  • The specific resolutions to be transacted at the EGM have not been detailed in this Regulation 30 intimation filed with the exchanges.

About the Company

Natural Capsules Limited (NSE:NATCAPSUQ) is a Bengaluru-headquartered manufacturer of hard gelatin capsule shells used in the pharmaceutical and nutraceutical industries. The company operates two manufacturing units: one at KIADB Industrial Area, Attibele, Bengaluru, and a second at Pitchaiveeranpet, Pondicherry. It holds ISO 9001:2015 and ISO 14001:2015 certifications and is listed on both BSE (scrip code 524654) and NSE.

Announcement in Detail

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Natural Capsules Limited submitted to both BSE Limited and the National Stock Exchange of India Limited copies of newspaper advertisements published on August 18, 2026. The advertisements, appearing in Business Line (an English-language financial daily) and Sanjevani (a Kannada-language publication), served as a public notice to equity shareholders regarding the forthcoming Extraordinary General Meeting.

The EGM is to be convened on Wednesday, September 9, 2026, at 12:00 PM IST. Given current SEBI and Ministry of Corporate Affairs guidelines permitting virtual meetings, the meeting will be conducted entirely through Video Conferencing or Other Audio Visual Means, allowing shareholders to participate remotely. The filing was signed by Akshay Dutta, Company Secretary and Compliance Officer (Membership No. A80481), on behalf of Natural Capsules Limited. The corporate and registered office of the company is located at Trident Towers, No. 23, 4th Floor, 100 Feet Road, 2nd Block, Bengaluru 560011.

Impact on Investors

Investors will note that this filing is a notice of an upcoming EGM and not an outcome. The specific resolutions to be placed before shareholders at the September 9, 2026 meeting have not been disclosed in this Regulation 30 intimation. Shareholders should monitor the company's official EGM notice, which will contain the full agenda, explanatory statement, and remote e-voting instructions, as required under the Companies Act, 2013.

The filing shows that equity shareholders are the primary addressees of the EGM notice. Until the complete EGM notice with agenda is made available, the disclosed terms do not indicate any immediate change to the company's capital structure, dividend policy, or governance framework. Shareholders will observe that participation via VC or OAVM means physical attendance is not required or applicable for this meeting.

Sector / Market Context

India's hard gelatin capsule manufacturing sector supplies both domestic pharmaceutical companies and export markets, with the Indian pharmaceutical industry being one of the largest globally by volume. SEBI's LODR framework mandates timely public disclosure of shareholder meeting notices, including newspaper publication in regional languages, to ensure that geographically dispersed retail shareholders receive adequate advance notice of material corporate events. This dual-language publication practice, combining an English financial daily with a vernacular newspaper, reflects the regulatory requirement to reach shareholders across linguistic demographics in the company's home state of Karnataka.

Unlock Premium Articles for Exclusive Insights!

Disclaimer:

The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

Copyright 2026 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.